KH2014 Suositus KH2014 Suositus

Tulosta

Antikolinergien käyttö virtsankarkailun hoidossa haurailla, usein monisairailla ja muistihäiriöisillä iäkkäillä

Lisätietoa aiheesta
2.12.2011
Maria Nuotio

Kirjallisuutta

  1. Kraus SR, Bavendam T, Brake T ym. Vulnerable elderly patients and overactive bladder syndrome. Drugs Aging 2010;27:697-713 «PMID: 20809661»PubMed
  2. Kay GG, Granville LJ. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Clin Ther 2005;27:127-38; quiz 139-40 «PMID: 15763613»PubMed
  3. Kay GG, Abou-Donia MB, Messer WS Jr ym. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005;53:2195-201 «PMID: 16398909»PubMed
  4. Popescu BO, Toescu EC, Popescu LM ym. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 2009;283:99-106 «PMID: 19264328»PubMed
  5. Paquette A, Gou P, Tannenbaum C. Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events? J Am Geriatr Soc 2011;59:1332-9 «PMID: 21718264»PubMed
  6. Kay G, Crook T, Rekeda L ym. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006;50:317-26 «PMID: 16687205»PubMed
  7. Fick DM, Cooper JW, Wade WE ym. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24 «PMID: 14662625»PubMed
  8. Donnellan CA, Fook L, McDonald P ym. Oxybutynin and cognitive dysfunction. BMJ 1997;315:1363-4 «PMID: 9402781»PubMed
  9. Katz IR, Sands LP, Bilker W ym. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc 1998;46:8-13 «PMID: 9434659»PubMed
  10. Tsao JW, Heilman KM. Transient memory impairment and hallucinations associated with tolterodine use. N Engl J Med 2003;349:2274-5 «PMID: 14657444»PubMed
  11. Staskin D, Kay G, Tannenbaum C ym. Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder. Int J Clin Pract 2010;64:1294-300 «PMID: 20561092»PubMed
  12. Lipton RB, Kolodner K, Wesnes K. Assessment of cognitive function of the elderly population: effects of darifenacin. J Urol 2005;173:493-8 «PMID: 15643227»PubMed
  13. Edwards KR, O'Connor JT. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors. J Am Geriatr Soc 2002;50:1165-6 «PMID: 12110086»PubMed
  14. Gill SS, Mamdani M, Naglie G ym. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 2005;165:808-13 «PMID: 15824303»PubMed
  15. Sink KM, Thomas J 3rd, Xu H ym. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc 2008;56:847-53 «PMID: 18384584»PubMed
  16. Isik AT, Celik T, Bozoglu E ym. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging 2009;13:672-6 «PMID: 19657549»PubMed
  17. Siegler EL, Reidenberg M. Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia. Clin Pharmacol Ther 2004;75:484-8 «PMID: 15116061»PubMed
  18. Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl 2002;:45-63 «PMID: 12139367»PubMed
  19. Hashimoto M, Imamura T, Tanimukai S ym. Urinary incontinence: an unrecognised adverse effect with donepezil. Lancet 2000;356:568 «PMID: 10950240»PubMed
  20. Carrière I, Fourrier-Reglat A, Dartigues JF ym. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 2009;169:1317-24 «PMID: 19636034»PubMed
  21. Jessen F, Kaduszkiewicz H, Daerr M ym. Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci 2010;260 Suppl 2:S111-5 «PMID: 20960005»PubMed
  22. Wagg A, Verdejo C, Molander U. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. Int J Clin Pract 2010;64:1279-86 «PMID: 20529135»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
KÄYPÄ HOITO -SUOSITUS Virtsankarkailu (naiset)
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko